PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33973101-2	2021	Fatty acid synthase (FASN) is a key enzyme for the de novo synthesis of fatty acids, and monoacylglycerol esterase (MGLL) is an important metabolic enzyme that converts triglycerides into free fatty acids.	Fatty Acids, Nonesterified	188-204	monoglyceride lipase	Homo sapiens	89-114	
20085702-3	2010	(2010) now demonstrate that an increase in monoacylglycerol lipase (MAGL) drives tumorigenesis through the lipolytic release and remodeling of free fatty acids.	Fatty Acids, Nonesterified	143-159	monoglyceride lipase	Homo sapiens	43-66	
20085702-3	2010	(2010) now demonstrate that an increase in monoacylglycerol lipase (MAGL) drives tumorigenesis through the lipolytic release and remodeling of free fatty acids.	Fatty Acids, Nonesterified	143-159	monoglyceride lipase	Homo sapiens	68-72	
33973101-2	2021	Fatty acid synthase (FASN) is a key enzyme for the de novo synthesis of fatty acids, and monoacylglycerol esterase (MGLL) is an important metabolic enzyme that converts triglycerides into free fatty acids.	Fatty Acids, Nonesterified	188-204	monoglyceride lipase	Homo sapiens	116-120	
35522977-3	2022	MAGL expression is increased in invasive tumors, furnishing free fatty acids as pro-tumorigenic signals and for tumor cell growth.	Fatty Acids, Nonesterified	60-76	monoglyceride lipase	Homo sapiens	0-4	
34823884-6	2022	This nanoplatform could utilize its reduction-responsive characteristic to rapidly release siRNA for efficient silencing of MGLL and CB-2, inducing concurrent suppression of free fatty acids (FFAs) generation in PAC cells and repolarization of TAMs into tumor-inhibiting M1-like phenotype.	Fatty Acids, Nonesterified	174-190	monoglyceride lipase	Homo sapiens	124-128	
33632876-2	2021	An important enzyme for the endocannabinoid metabolism is the monoacylglycerol lipase (MAGL), which catalyzes the degradation of 2-arachidonoylglycerol (2-AG) to glycerol and free fatty acids.	Fatty Acids, Nonesterified	175-191	monoglyceride lipase	Homo sapiens	62-85	
33632876-2	2021	An important enzyme for the endocannabinoid metabolism is the monoacylglycerol lipase (MAGL), which catalyzes the degradation of 2-arachidonoylglycerol (2-AG) to glycerol and free fatty acids.	Fatty Acids, Nonesterified	175-191	monoglyceride lipase	Homo sapiens	87-91	
30059673-2	2018	Besides this role, MAGL has progressively acquired a growing importance as an integrative metabolic hub that controls not only the in vivo levels of 2-AG but also of other monoacylglycerides and, indirectly, the levels of free fatty acids derived from their hydrolysis as well as other lipids with pro-inflammatory or pro-tumorigenic effects, coming from the further metabolism of fatty acids.	Fatty Acids, Nonesterified	222-238	monoglyceride lipase	Homo sapiens	19-23	
33085920-2	2021	Importantly, it was found that MAGL degradation of lipids in cancer cells enhances the availability of free fatty acids for new cellular membrane formation and pro-oncogenic lipid modulators.	Fatty Acids, Nonesterified	103-119	monoglyceride lipase	Homo sapiens	31-35	
30034939-2	2018	Monoglyceride lipase (MGLL) is an important fatty acid metabolism enzyme, which converts monoacylglycerides to free fatty acids and glycerol.	Fatty Acids, Nonesterified	111-127	monoglyceride lipase	Homo sapiens	0-20	
30034939-2	2018	Monoglyceride lipase (MGLL) is an important fatty acid metabolism enzyme, which converts monoacylglycerides to free fatty acids and glycerol.	Fatty Acids, Nonesterified	111-127	monoglyceride lipase	Homo sapiens	22-26	
25120746-1	2014	Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerides into free fatty acids and glycerol.	Fatty Acids, Nonesterified	93-109	monoglyceride lipase	Homo sapiens	0-23	
25120746-1	2014	Monoacylglycerol lipase (MAGL) is a serine hydrolase that hydrolyzes monoacylglycerides into free fatty acids and glycerol.	Fatty Acids, Nonesterified	93-109	monoglyceride lipase	Homo sapiens	25-29